Citadel Advisors - ITERUM THERAPEUTICS PLC ownership

ITERUM THERAPEUTICS PLC's ticker is ITRM and the CUSIP is G6333L101. A total of 13 filers reported holding ITERUM THERAPEUTICS PLC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of ITERUM THERAPEUTICS PLC
ValueSharesWeighting
Q1 2022$18,000
+100.0%
50,515
+125.6%
0.00%
Q4 2021$9,000
-94.4%
22,390
-67.7%
0.00%
Q2 2021$160,000
-17.1%
69,354
-49.4%
0.00%
Q1 2021$193,000
+21.4%
137,026
-14.5%
0.00%
Q4 2020$159,000
+1225.0%
160,334
+1312.1%
0.00%
Q3 2020$12,00011,3540.00%
Other shareholders
ITERUM THERAPEUTICS PLC shareholders Q3 2020
NameSharesValueWeighting ↓
Canaan Partners X LLC 1,733,170$346,0000.60%
New Leaf Venture Partners, L.L.C. 1,456,303$292,0000.19%
GSA CAPITAL PARTNERS LLP 304,684$61,0000.01%
Krilogy Financial LLC 200,000$40,0000.01%
Focused Wealth Management, Inc 105,000$21,0000.00%
Virtu Financial LLC 110,470$22,0000.00%
GRIMES & COMPANY, INC. 179,396$36,0000.00%
IFP Advisors, Inc 6,000$72,0000.00%
Principle Wealth Partners LLC 30,000$6,0000.00%
OSAIC HOLDINGS, INC. 1,280$00.00%
View complete list of ITERUM THERAPEUTICS PLC shareholders